← Back to Clinical Trials
Recruiting NCT06829303

BCI Training for Social Cognition and Error Monitoring in ASD

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Autism Spectrum Disorder (ASD)
Sponsor University of Coimbra
Study Type INTERVENTIONAL
Phase N/A
Enrollment 28
Sex ALL
Min Age 16 Years
Max Age 55 Years
Start Date 2025-03-01
Completion 2026-09
Interventions
Emotional Facial Expression Paradigm (EFP)Speller task

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Social cognition seems to develop atypically in autism, particularly in processes such as faces perception, joint attention and social information processing. In this sense, and using an Emotional Paradigm of Facial Expressions (EFP) with a Brain-Computer Interface (BCI) based on Electroencephalography (EEG), the investigators intend to evaluate its effectiveness as a medical device in Autism Spectrum Disorder (ASD), namely: improving 1) social skills and 2) reducing generalized anxiety, 3) improve error monitoring, and consequently verify 4) an increase in motivation. To this end, the investigators will test a gamified intervention (EFP), using personalized feedback in real time. In this gamified interface, there is an artificial agent that learns rules through Reinforcement Learning using the evoked potentials from the participant as they observe the agent's right or wrong actions. The hypothesis is that this approach allows, during the gamified task (EFP), not only the agent/interface to learn, but also the participant through operant conditioning and implicit scrutiny of errors, which makes it particularly interesting for disorders in which error monitoring processes are compromised, as in ASD.

Eligibility Criteria

Inclusion Criteria: * Participant is able and willing to give written informed consent/assent * Previous diagnosis of Autism Spectrum Disorder by a qualified clinician according to gold-standard instruments * Aged between 16 and 55 years old * Normal or corrected-to-normal vision Exclusion Criteria: * Global Intelligence Quotient \<70 * Dermatological diseases of the scalp * Concurrent neurofeedback therapy * Concomitant medication without a stable dosage for at least 4 weeks * History of seizures and/or epilepsy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}